Alpine Woods Capital Investors LLC Takes $1.04 Million Position in CME Group Inc. $CME

Key Points

• Alpine Woods Capital Investors acquired 4,718 CME Group shares worth approximately $1.04 million during the second quarter. Institutional investors collectively own 87.75% of the company, with several major firms also initiating substantial positions.
• CME Group exceeded quarterly expectations, reporting $2.99 in EPS and $1.71 billion in revenue, while revenue increased 0.8% year over year. The company declared a quarterly dividend of $1.30 per share, equivalent to a 1.9% annual yield.
• Analyst opinions remain mixed: CME has a consensus rating of “Hold” and an average price target of $291.81, compared with a reported share price of $271.54.

Alpine Woods Capital Investors LLC bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,718 shares of the financial services provider's stock, valued at approximately $1,042,000.

A number of other institutional investors have also recently bought and sold shares of CME. BlackRock Inc. purchased a new position in shares of CME Group in the 2nd quarter worth $6,749,965,000. Norges Bank purchased a new stake in CME Group during the fourth quarter valued at about $1,523,241,000. Bank of New York Mellon Corp purchased a new stake in CME Group during the second quarter valued at about $867,313,000. Alphabet Inc. acquired a new stake in CME Group during the second quarter worth about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in CME Group during the second quarter worth about $629,771,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.30% of the company's stock.

CME Group Price Performance

CME stock opened at $271.54 on Wednesday. The firm has a market cap of $97.64 billion, a P/E ratio of 23.03, a price-to-earnings-growth ratio of 3.14 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a 50-day simple moving average of $250.82 and a 200-day simple moving average of $279.97.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group's revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the company posted $2.96 EPS. On average, equities analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 44.11%.

Analysts Set New Price Targets

CME has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft reduced their price objective on CME Group from $342.00 to $322.00 and set a "buy" rating on the stock in a research note on Thursday, April 23rd. TD Cowen dropped their target price on shares of CME Group from $323.00 to $273.00 and set a "buy" rating for the company in a research report on Monday, June 22nd. Keefe, Bruyette & Woods upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target on the stock in a report on Thursday, June 18th. Barclays reduced their price target on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 9th. Finally, Raymond James Financial reiterated an "outperform" rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $291.81.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source